CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
95.48
-0.59 (-0.61%)
Sep 9, 2026, 1:15 PM EDT - Market open
CVS Health Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 122,116 | 100,742 | 56,490 | 101,613 | 122,449 | 136,274 | |
Market Cap Growth | 30.50% | 78.34% | -44.41% | -17.02% | -10.15% | 52.43% |
Enterprise Value | 184,464 | 171,444 | 129,676 | 165,694 | 173,860 | 202,401 |
Last Close Price | 96.07 | 77.55 | 42.07 | 71.02 | 81.20 | 87.90 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 25.17 | 56.98 | 12.24 | 12.18 | 28.40 | 17.03 |
Forward PE | 11.83 | 11.54 | 7.77 | 9.39 | 10.67 | 12.88 |
PS Ratio | 0.30 | 0.25 | 0.15 | 0.28 | 0.38 | 0.47 |
PB Ratio | 1.54 | 1.34 | 0.75 | 1.33 | 1.71 | 1.81 |
P/FCF Ratio | 10.38 | 12.90 | 8.93 | 9.78 | 9.10 | 8.65 |
P/OCF Ratio | 8.26 | 9.47 | 6.20 | 7.57 | 7.57 | 7.46 |
PEG Ratio | 1.12 | 0.76 | 0.61 | 1.92 | 2.05 | 2.15 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.45 | 0.43 | 0.35 | 0.47 | 0.54 | 0.70 |
EV/EBITDA Ratio | 11.06 | 11.72 | 10.28 | 8.99 | 8.71 | 10.86 |
EV/EBIT Ratio | 15.17 | 17.11 | 16.17 | 11.77 | 11.04 | 14.30 |
EV/FCF Ratio | 15.68 | 21.96 | 20.50 | 15.94 | 12.93 | 12.86 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.96 | 1.06 | 1.10 | 1.04 | 0.99 | 1.01 |
Debt / EBITDA Ratio | 3.87 | 4.53 | 5.30 | 3.68 | 3.06 | 3.48 |
Debt / FCF Ratio | 6.49 | 10.24 | 13.11 | 7.64 | 5.26 | 4.83 |
Net Debt / Equity Ratio | 0.78 | 0.92 | 0.95 | 0.89 | 0.77 | 0.84 |
Net Debt / EBITDA Ratio | 3.74 | 4.74 | 5.70 | 3.68 | 2.76 | 3.41 |
Net Debt / FCF Ratio | 5.30 | 8.88 | 11.37 | 6.54 | 4.09 | 4.03 |
Asset Turnover | 1.61 | 1.58 | 1.47 | 1.49 | 1.40 | 1.25 |
Inventory Turnover | 20.32 | 18.56 | 17.79 | 16.35 | 14.54 | 13.24 |
Quick Ratio | 0.62 | 0.57 | 0.56 | 0.59 | 0.62 | 0.55 |
Current Ratio | 0.87 | 0.84 | 0.81 | 0.86 | 0.95 | 0.89 |
Return on Equity (ROE) | 6.21% | 2.29% | 6.02% | 11.28% | 5.88% | 11.01% |
Return on Assets (ROA) | 2.97% | 2.47% | 1.99% | 3.68% | 4.27% | 3.82% |
Return on Invested Capital (ROIC) | 7.17% | 5.54% | 4.09% | 7.77% | 8.79% | 7.59% |
Return on Capital Employed (ROCE) | 7.30% | 6.10% | 4.80% | 8.30% | 9.90% | 8.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.01% | 1.75% | 8.17% | 8.21% | 3.52% | 5.87% |
FCF Yield | 9.63% | 7.75% | 11.20% | 10.23% | 10.98% | 11.55% |
Dividend Yield | 2.79% | 3.43% | 6.32% | 3.41% | 2.71% | 2.27% |
Payout Ratio | 69.70% | 192.14% | 73.10% | 37.54% | 67.43% | 32.81% |
Buyback Yield / Dilution | -1.19% | -0.71% | 2.17% | 2.49% | 0.45% | -1.14% |
Total Shareholder Return | 1.60% | 2.72% | 8.49% | 5.90% | 3.16% | 1.13% |